Stockreport

Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The company plans to begin a phase I/II study soon, which will evaluate the immunogenicity and safety of the vaccine candidate in adults aged between 18 and 29 years. [Read more]